By reducing systemic inflammation, GLP-1 may benefit individuals with chronic conditions like non-alcoholic fatty liver disease (NAFLD), rheumatoid arthritis, and even metabolic syndrome
Nausea and Vomiting Up to 50% of patients experience nausea, especially in the first few weeks
Diabetologia 61:21082117 Ganbaatar B, Fukuda D, Shinohara M, Yagi S, Kusunose K, Yamada H, Soeki T, Hirata KI, Sata M (2020) Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice
2 Local Experience, Every Conversation Youll speak with someone who understands your community and rights
Your doctor will make this decision based on your individual health needs